Skip to main content
. 2018 May 27;23(6):1285. doi: 10.3390/molecules23061285

Table 2.

Identification of UHPLC/DAD/ESI-MSn data, and quantification of the most relevant compounds from the ethanolic extract of S. stellata (Retention time (Rt), wavelength of maximum absorption in the UV-Vis region (λmax), pseudomolecular and MSn fragment ions, quantification (mean ± SD) and identification of the phenolic compounds).

Rt (min) λmax [M − H] (m/z) ESI-MS2; (MS3) (m/z) Quantity Compound
1.38 191, 267 387 341, 369; (179, 143, 161) 8.24 ± 0.03 1-Caffeoylglucose derivative (b)
1.74 193, 202 128 85, 109 4.30 ± 0.02 Cyanuric acid (a)
4.35 204, 324 353 191, 179, 135; (173, 127, 109) nq 1-O-Caffeoylquinic acid (c)
5.30 211, 278, 323 223 205, 115, 143, 159 0.26 ± 0.01 Sinapic acid (a)
6.66 217, 298, 325 353 191, 179, 173, 135; (111, 93) 26.41 ± 0.30 4-O-Caffeoylquinic acid (c)
7.12 216, 299, 325 353 191, 179; (173, 127, 85) 8.93 ± 0.12 3-O-Caffeoylquinic acid (a)
8.40 206, 269, 348 609 489, 447, (357, 327, 285) 1.84 ± 0.03 Luteolin-6-C-glucoside-7-O-glucoside (b)
8.55 199, 214, 270, 304 353 191, 179, 135; (173, 127, 85) 1.47 ± 0.01 5-O-Caffeoylquinic acid (c)
8.83 220, 274, 310 337 191, 173; (127, 110, 93) tr 5-O-p-Coumaroylquinic acid (c)
9.83 230, 326 367 191; (173, 85) 0.97 ± 0.02 5-O-Feruloylquinic acid (c)
10.14 209, 269, 350 447 429, 357, 327; (309, 297, 285) 66.31 ± 0.30 Isoorientin (luteolin-6-C-glucoside) (a)
10.40 211, 269, 350 579 561, 447, 357, 327; (309, 297, 285) 9.78 ± 0.26 Luteolin-2″-O-pentosyl-6-C-hexoside (b)
10.65 211, 270, 346 461 371, 341, 313; (299, 231) 13.97 ± 0.11 Diosmetin-6(or 8)-C-glucoside (b)
11.90 225, 270, 338 563 443, 431; (311, 283, 269) 2.82 ± 0.01 Apigenin-2″-O-pentosyl-8-C-glucoside (b)
12.38 232, 256, 353 463 301; (268, 179, 151) 0.97 ± 0.04 Quercetin-3-O-glucoside (hyperoside) (b)
13.99 220, 241, 327 515 353; (191, 173) 16.03 ± 0.03 4,5-O-Dicaffeoylquinic acid (a)
14.21 237, 267, 337 609 489, 369; (298, 285, 231) 1.23 ± 0.01 Lucenin 2 (luteolin-6,8-di-C-glucoside) (b)
14.38 242, 326 515 353, 335; (173,111) tr 3,4-O-Dicaffeoylquinic acid (c)
14.93 240, 268, 314 639 616, 315 tr Tamarixetin-O,O-dihexoside (b)
15.18 242, 326 515 353; (191, 171, 127) 3.74 ± 0.02 3,5-O-Dicaffeoylquinic acid (c)
18.26 239, 270, 351 613 489, 447, 429; (369, 309, 285) 0.43 ± 0.02 Luteolin-6-C-glucoside derivative (b)
19.02 243, 267, 314 593 447, 285 0.37±0.02 Tiliroside (b)
20.86 237, 267, 314 635 477, 315 14.49 ± 0.02 Tamarixetin derivative (b)
20.94 237, 267, 313 769 623, 477, 315 nq Tamarixetin glycoside (a)
21.30 243, 269, 313 739 593, 447, 285 10.85 ± 0.01 Kaempferol-3-O-rutinoside derivative (b)
57.55 ± 0.11 Total chlorogenic acids
108.20 ± 0.17 Total flavonoids

molecular ion; main fragments; mg of compound/g dried extract; nq—not quantified; tr—traces; obtained by propagation. Compounds were identified by (a) comparison with pure standards, commercially available or isolated; (b) comparison with pure aglycone and literature data; (c) comparison with pure cinnamic acid derivative and literature data.